Oren Gilad, CEO of Aprea Therapeutics APRE, has filed 8 purchases and 0 sales on the open market. Over the past 12 months that comes to a net purchase of $25K. The latest trade was on 03/12.

OG

OG

Oren Gilad

President/CEO

Company

Aprea Therapeutics APRE

First filing

23/03/13

Trades

23 trades

Buys / sales

8 / 0

12-month net buying

$25K

Last trade

03/12

FollowShare

Trading activity

6 months1 year2 years5 yearsAll

Transactions

Company	Trade type	Traded	Filed	Shares	Price	Value	Holding change
Aprea TherapeuticsAPRE	Open-market buy	01/30	02/02	28,100 sh	$0.89	$25,009	+8.1%
Aprea TherapeuticsAPRE	Open-market buy	25/04/03	25/04/04	5,500 sh2 trades	$1.84avg.	$10,110.21	+1.6%
Aprea TherapeuticsAPRE	Open-market buy	24/10/23	24/10/24	500 sh	$3.92	$1,960	+0.2%
Aprea TherapeuticsAPRE	Open-market buy	24/10/15	24/10/16	250 sh	$2.90	$725	+0.1%
Aprea TherapeuticsAPRE	Open-market buy	24/10/10–24/10/14	24/10/15	1,150 sh2 trades	$2.58avg.	$2,971	+0.3%
Aprea TherapeuticsAPRE	Open-market buy	24/03/13	24/03/14	2,000 sh	$7.29	$14,580	+0.6%